|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
Hyposphatemia Treatment |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
There are a variety of different
formulations of phosphate available, both in enteral and parenteral form.
The route of administration depends on the speed and availability of that
route. Of the parenteral formulations, both sodium and potassium phosphate
are available. I usually use the potassium preparation, as most ICU patients
are deficient in both potassium and phosphate. In addition, I almost always
add KPO4 to the dialysis fluid in CVVHDF. If the patient is severely
hypophosphatemic, then intravenous replenishment at 6mg/kg/hour is
administered until the PO4 level is above 2mg/dl.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Please note: these tutorials are for personal study purposes only. They are not currently peer reviewed, and no responsibility will be taken for mistakes or inaccuracies. Reproduction of information is forbidden. All material is copyrighted by the GasWorks Group. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||